Drug intelligence / Profile preview

alpha-lipoic acid + high molecular weight sodium hyaluronate

Development stage
Unknown
Modality
Small Molecules, Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic, Topical
01

Overview

Alpha-lipoic acid combined with high molecular weight sodium hyaluronate is formulated as a preservative-free ophthalmic emulsion primarily used to manage oxidative stress and inflammation on the ocular surface, particularly in patients with dry eye disease. Alpha-lipoic acid acts as an antioxidant that can reduce oxidative damage and inflammation, while high molecular weight sodium hyaluronate provides lubrication, hydration, anti-inflammatory effects, and supports tissue repair. The combination shows synergistic benefits improving quality of life scores and markers of oxidative stress and inflammation in dry eye disease patients. This formulation leverages alpha-lipoic acid’s antioxidant properties alongside the viscoelastic and anti-inflammatory actions of high molecular weight sodium hyaluronate to enhance ocular surface health[1][4][6].

02

Targets

CD44 (CD44 antigen)STAB2 (Stabilin-2)ICAM1 (Intercellular Adhesion Molecule 1)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)RHAMM (Hyaluronan-mediated motility receptor)

Beyond the preview

Go deeper on alpha-lipoic acid + high molecular weight sodium hyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-lipoic acid + high molecular weight sodium hyaluronate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call